Assembly Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $283.3M
Liabilities Breakdown FY2020
Total Liabilities: $42.7M
Asset Breakdown
Total Assets: $283.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $59.4M | 21.0% |
| Accounts Receivable | $1.2M | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.6M | 0.6% |
| Goodwill | $12.6M | 4.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $208.3M | 73.6% |
Liabilities Breakdown
Total Liabilities: $42.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.6M | 10.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.1M | 89.2% |